2022
Incarceration status and cancer mortality: A population-based study
Oladeru OT, Aminawung JA, Lin HJ, Gonsalves L, Puglisi L, Mun S, Gallagher C, Soulos P, Gross CP, Wang EA. Incarceration status and cancer mortality: A population-based study. PLOS ONE 2022, 17: e0274703. PMID: 36112653, PMCID: PMC9481043, DOI: 10.1371/journal.pone.0274703.Peer-Reviewed Original ResearchConceptsPopulation-based studyStage of diagnosisCancer mortalityInvasive cancerCancer diagnosisOverall survival rateCancer-related deathImmediate post-release periodCause mortalityTumor RegistryCancer characteristicsCancer survivalWorse outcomesCancer preventionHigh riskSurvival rateCancerMortalityIncarceration statusAdult residentsStudy periodTreatment effortsDiagnosisFive yearsPost-release period
2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.
Edwards JK, Cole SR, Breger TL, Rudolph JE, Filiatreau LM, Buchacz K, Humes E, Rebeiro PF, D'Souza G, Gill MJ, Silverberg MJ, Mathews WC, Horberg MA, Thorne J, Hall HI, Justice A, Marconi VC, Lima VD, Bosch RJ, Sterling TR, Althoff KN, Moore RD, Saag M, Eron JJ. Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study. Annals Of Internal Medicine 2021, 174: 1197-1206. PMID: 34224262, PMCID: PMC8453103, DOI: 10.7326/m21-0065.Peer-Reviewed Original ResearchConceptsGeneral U.S. populationHIV careU.S. populationNorth American AIDS Cohort CollaborationHIV clinical careObservational cohort studyTreatment of adultsRace/ethnicityCohort CollaborationCause mortalityCohort studyHIV infectionModifiable factorsComparable personsObservational studyClinical careHigh riskGeneral populationSociodemographic factorsHealth StatisticsMortalityHIVKaplan-Meier estimatorCareFive years
2019
Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx
Chen PH, Yang Y, O'Malley DP, Xu ML. Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx. Annals Of Diagnostic Pathology 2019, 41: 129-135. PMID: 31247533, DOI: 10.1016/j.anndiagpath.2019.06.007.Peer-Reviewed Original ResearchConceptsB-cell non-Hodgkin lymphomaEBV-negative casesAggressive B-NHLPD-L1Peptide receptor radionuclide therapyAggressive B-cell lymphomasEBV-positive DLBCLEBV-positive patientsDisease-free intervalPrimary clinical outcomeYear of diagnosisEBV-positive casesReceptor radionuclide therapyExpression of SSTR2Non-Hodgkin lymphomaExpression of CD30Five yearsAvailable outcome dataB-cell lymphomaEBV negativityInitial therapyClinicopathologic characteristicsBetter prognosisCase seriesClinical outcomes
2018
Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium
Petridou ET, Georgakis MK, Erdmann F, Ma X, Heck JE, Auvinen A, Mueller BA, Spector LG, Roman E, Metayer C, Magnani C, Pombo-de-Oliveira MS, Ezzat S, Scheurer ME, Mora AM, Dockerty JD, Hansen J, Kang AY, Wang R, Doody DR, Kane E, Rashed WM, Dessypris N, Schüz J, Infante-Rivard C, Skalkidou A. Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium. European Journal Of Epidemiology 2018, 33: 965-976. PMID: 29761423, PMCID: PMC6384148, DOI: 10.1007/s10654-018-0402-z.Peer-Reviewed Original ResearchConceptsAcute lymphoblastic leukemiaChildhood Leukemia International ConsortiumChildhood acute lymphoblastic leukemiaCase-control studyAdvanced parental ageLymphoblastic leukemiaOdds ratioParental agePaternal ageAdvanced maternal ageSimilar positive associationPositive associationAdverse health effectsMaternal ageRisk factorsEnrollment periodStudy designAge incrementsHealth effectsFive yearsAgeUnderlying mechanismInternational ConsortiumLeukemiaRisk
2015
Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine
Tahita M, Tinto H, Erhart A, Kazienga A, Fitzhenry R, VanOvermeir C, Rosanas-Urgell A, Ouedraogo J, Guiguemde R, Van geertruyden J, D’Alessandro U. Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine. PLOS ONE 2015, 10: e0137440. PMID: 26368675, PMCID: PMC4569438, DOI: 10.1371/journal.pone.0137440.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntimalarialsBurkina FasoDihydropteroate SynthaseDrug CombinationsDrug ResistanceFemaleHumansMalaria, FalciparumMutationPlasmodium falciparumPregnancyPregnancy Trimester, SecondPregnancy Trimester, ThirdPrevalenceProtozoan ProteinsPyrimethamineSulfadoxineTetrahydrofolate DehydrogenaseYoung AdultConceptsIntermittent preventive treatmentPregnant womenPfdhps genesPreventive treatmentAntenatal careSulfadoxine-pyrimethamineThird trimesterDhps mutationsPfdhfr mutationsMalaria infectionMalaria symptomsHealth districtPfdhfr geneBlood samplesSP resistanceI164L mutationEndemic regionsReductase mutationMalaria controlDrug resistancePrevalenceAdverse effectsFive yearsWomenBurkina FasoDynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
Sondo P, Derra K, Tarnagda Z, Nakanabo S, Zampa O, Kazienga A, Valea I, Sorgho H, Ouedraogo J, Guiguemde T, Tinto H. Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso. Pan African Medical Journal 2015, 21: 101. PMID: 26516402, PMCID: PMC4606025, DOI: 10.11604/pamj.2015.21.101.6437.Peer-Reviewed Original Research
2014
Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
Tinto H, Bonkian L, Nana L, Yerbanga I, Lingani M, Kazienga A, Valéa I, Sorgho H, Kpoda H, Guiguemdé T, Ouédraogo J, Mens P, Schallig H, D’Alessandro U. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change. Malaria Journal 2014, 13: 207. PMID: 24885950, PMCID: PMC4049403, DOI: 10.1186/1475-2875-13-207.Peer-Reviewed Original ResearchConceptsP. falciparum sensitivityVivo studiesFirst-line treatmentPlasmodium falciparum fieldAnti-malarial drugsEx vivo studyDrug sensitivity profilesDHA-PPQChloroquine resistanceIC50 valuesPartner drugsDrug efficacy testsDrug measurementsInhibitory concentration valuesMonodesethylamodiaquinePiperaquineEfficacy of ALHigher IC50 valuesPlasmodium falciparumDihydroartemisininFive yearsCellular proliferationDrugsRecent reportsLumefantrineAmputation Neuroma Growing Intravascularly Into a Thrombus
Schulz WL, Manivel JC. Amputation Neuroma Growing Intravascularly Into a Thrombus. International Journal Of Surgical Pathology 2014, 22: 645-646. PMID: 24477938, DOI: 10.1177/1066896913520038.Peer-Reviewed Original ResearchSpirometry in primary care for children with asthma.
Banasiak NC. Spirometry in primary care for children with asthma. Pediatric Nursing 2014, 40: 195-8. PMID: 25269360.Peer-Reviewed Original Research
2013
Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples
Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples. New England Journal Of Medicine 2013, 369: 1715-1725. PMID: 24171517, PMCID: PMC3913536, DOI: 10.1056/nejmsa1214720.Peer-Reviewed Original ResearchConceptsEarly antiretroviral therapyHuman immunodeficiency virusAntiretroviral therapySerodiscordant couplesHIV transmissionHIV Prevention Trials Network 052 studyIncremental cost-effectiveness ratioCost-effectiveness ratioResource-limited settingsHIV infectionClinical benefitImmunodeficiency virusHIV treatmentLonger survivalOpportunistic diseasesEarly initiationFive yearsLifetime outcomesPublic healthSuch personsPatientsPeriodTherapyInfectionDiseaseP084: Analysis of therapeutic efficacies of amodiaquine-arstesunate and artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Burkina Faso five years after their implementation
Nikiema F, Zongo I, Some F, Ouedraogo J, Penali L. P084: Analysis of therapeutic efficacies of amodiaquine-arstesunate and artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Burkina Faso five years after their implementation. Antimicrobial Resistance & Infection Control 2013, 2: p84. PMCID: PMC3688426, DOI: 10.1186/2047-2994-2-s1-p84.Peer-Reviewed Original Research
2012
Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: Five-year Follow-up
Zebardast N, Adelman RA. Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: Five-year Follow-up. Seminars In Ophthalmology 2012, 27: 61-64. PMID: 22784267, DOI: 10.3109/08820538.2012.680644.Peer-Reviewed Original ResearchConceptsChoroidal neovascularizationOptical coherence tomographyPseudoxanthoma elasticumFluorescein angiographyNeovascular activityTreatment of CNVIntravitreal ranibizumab injectionsFive yearsMacular choroidal neovascularizationLong-term effectivenessOCT evidenceIntravitreal ranibizumabRanibizumab injectionsRanibizumab therapyAffected eyeIntraretinal fluidVisual acuityFluorescein leakageAngioid streaksScar formationInitial injectionCoherence tomographyRanibizumabInjectionNeovascularization
2011
Impact of the 26 December 2003 Bam Earthquake on Activities of Daily Living and Instrumental Activities of Daily Living of Older People
Ardalan A, Mazaheri M, Mowafi H, VanRooyen M, Teimoori F, Abbasi R. Impact of the 26 December 2003 Bam Earthquake on Activities of Daily Living and Instrumental Activities of Daily Living of Older People. Prehospital And Disaster Medicine 2011, 26: 99-108. PMID: 21888729, DOI: 10.1017/s1049023x11000045.Peer-Reviewed Original ResearchConceptsDaily livingElderly survivorsInstrumental activitiesFunctional capacityDaily living statusTwo-stage cluster surveyTerms of ADLLevel of ADLLower functional capabilitySelf-reported activityIADL scoresSimilar associationLiving statusOlder peopleADLSurvivorsMedical servicesFive yearsMonthsIADLCluster SurveyYearsLivingStatusMore problems
2010
Post-disaster quality of life among older survivors five years after the Bam earthquake: implications for recovery policy
ARDALAN A, MAZAHERI M, VANROOYEN M, MOWAFI H, NEDJAT S, NAIENI K, RUSSEL M. Post-disaster quality of life among older survivors five years after the Bam earthquake: implications for recovery policy. Ageing And Society 2010, 31: 179-196. DOI: 10.1017/s0144686x10000772.Peer-Reviewed Original ResearchSurvivors five yearsGeneral populationDisaster-affected communitiesEarthquake-related injuriesFive yearsWHOQOL-BREF questionnaireCross-sectional analysisSatisfactory housingGood social relationshipsBetter QOLRecovery policiesQoL assessmentFemale genderSocial relationshipsDaily livingLiving conditionsHigher ageHealth statusQoLMajor disastersOlder peopleBam earthquakeIntervention programsElders' qualityPoor quality
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply